A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Obesity

ProgenaBiome

Overview

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding obesity.

The goal of this Research Study is to better understand how the genetic information in subject's microbiome correlates to the information provided in surveys and in medical records, particularly regarding obesity.

Study Type

OBSERVATIONAL

Conditions

Overweight and Obesity Overweight or Obesity Obesity Obesity, Morbid Obesity, Abdominal Obesity; Familial Obesity; Endocrine Obesity, Visceral Obesity Hypoventilation Syndrome

Interventions

No interventionOTHER

There is no intervention for this study

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Signed informed consent by patient 2. Male or female patients age 18 and older. 3. Diagnosis of obesity based on Body Mass Index (BMI) of 30 or greater. Exclusion Criteria: 1. Refusal by patient to sign informed consent form 2. Treatment with antibiotics within two weeks prior to screening 3. Treatment with probiotics within six weeks prior to screening 4. History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy 5. Postoperative stoma, ostomy, or ileoanal pouch 6. Participation in any experimental drug protocol within the past 12 weeks 7. Treatment with total parenteral nutrition 8. Any clinically significant evidence of disease that could interfere with the subject's ability to enter the trial 9. Inability of patient to adequately communicate with the investigator or their respective designee and/or comply with the requirements of the entire study

Locations (1)

ProgenaBiome

Ventura, California, United States

Outcomes

Primary Outcomes

Correlation of Microbiome to Obesity via Relative Abundance Found in Microbiome Sequencing

Relative abundance of bacterial classes within taxonomic phyla and, more broadly, within their domain will be analyzed by sequencing the gut microbiome. These data will then be categorized among obesity types

Time frame: 1 year

Secondary Outcomes

Validation of Sequencing Methods

To validate the methods used to sequence samples

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.